living donor kidney transplantation
Conditions
Interventions
mizoribine group:Patients underwent treatment with combination therapy consisting of tacrolimus, steroid and mizoribineine
mycophenolate mofetil group:Patients underwent treatment with combination therapy consisting of tacrolimus, steroid and mycophenolate mofetil
Sponsors
General Hospital of Chinese People's Armed Police Forces
Eligibility
Sex/Gender
All
Age
16 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. First renal transplant recipients; 2. No consideration to be given to gender, age, or underlying; 3. Patients are willing to sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with serious infections or cardiac diseases; 2. Women who are pregnant or seeking to become pregnant during the study period; 3. Patients who treated with cyclosporine and azathioprine; 4. Patients who have a history of allergies to any investigational product (FK506,MZR,MMF) or steroids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the prevalence of GI Symptom; | — |
Secondary
| Measure | Time frame |
|---|---|
| the prevalence of AR;Clinical findings (index of renal function); | — |
Countries
China
Contacts
Public ContactYi Shi
Outcome results
None listed